Geneoscopy: Amit Bhalla

Geneoscopy has appointed Amit Bhalla as its CFO. He will support the launch of the firm’s ColoSense RNA-based, noninvasive colorectal cancer screening test. Bhalla has more than 25 years of experience in healthcare finance, strategy, and investment. He was most recently executive VP and CFO at Sampled, a biorepository and laboratory. Before that, he was VP of global strategy and development at Becton Dickinson, where he was also a member of the executive management committee. St. Louis-based Geneoscopy closed a $105 million Series C financing round in January to support the commercialization of ColoSense.